Structure

Physi-Chem Properties

Molecular Weight:  782.2
Volume:  726.517
LogP:  5.145
LogD:  2.324
LogS:  -5.209
# Rotatable Bonds:  5
TPSA:  118.87
# H-Bond Aceptor:  12
# H-Bond Donor:  1
# Rings:  9
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.412
Synthetic Accessibility Score:  7.751
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.451
MDCK Permeability:  1.3621872312796768e-05
Pgp-inhibitor:  0.99
Pgp-substrate:  0.779
Human Intestinal Absorption (HIA):  0.783
20% Bioavailability (F20%):  0.586
30% Bioavailability (F30%):  0.91

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.373
Plasma Protein Binding (PPB):  95.21968841552734%
Volume Distribution (VD):  1.661
Pgp-substrate:  2.6540679931640625%

ADMET: Metabolism

CYP1A2-inhibitor:  0.014
CYP1A2-substrate:  0.58
CYP2C19-inhibitor:  0.953
CYP2C19-substrate:  0.979
CYP2C9-inhibitor:  0.962
CYP2C9-substrate:  0.111
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.017
CYP3A4-inhibitor:  0.967
CYP3A4-substrate:  0.994

ADMET: Excretion

Clearance (CL):  9.151
Half-life (T1/2):  0.004

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.803
Drug-inuced Liver Injury (DILI):  0.996
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.802
Maximum Recommended Daily Dose:  0.021
Skin Sensitization:  0.909
Carcinogencity:  0.654
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.0

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC253987

Natural Product ID:  NPC253987
Common Name*:   Chaetocochin A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DOTYKRRRMXXIPL-ISYIGULMSA-N
Standard InCHI:  InChI=1S/C36H42N6O6S4/c1-37-30(46)36(52-7)20-48-21-40-26-15-11-9-13-24(26)32(18-34(50-5)29(45)38(2)35(19-43,51-6)31(47)42(34)27(32)40)41-17-22(23-12-8-10-14-25(23)41)16-33(37,49-4)28(44)39(36)3/h8-15,17,27,43H,16,18-21H2,1-7H3/t27-,32+,33+,34+,35+,36+/m1/s1
SMILES:  CS[C@@]12C[C@@]34[C@@H](N2C(=O)[C@](N(C1=O)C)(CO)SC)N(c1c3cccc1)COC[C@@]1(SC)N(C(=O)[C@](Cc2cn4c3ccccc23)(SC)N(C1=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454044
PubChem CID:   16086610
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000064] Macrolactams

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9444 Chaetomium cochliodes Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[16989540]
NPO9444 Chaetomium cochliodes Species Chaetomiaceae Eukaryota n.a. n.a. n.a. PMID[32115958]
NPO9444 Chaetomium cochliodes Species Chaetomiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 4.1 ug.mL-1 PMID[543731]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 3.4 ug.mL-1 PMID[543731]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 7.0 ug.mL-1 PMID[543731]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC253987 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9604 High Similarity NPC19170
0.9463 High Similarity NPC297862
0.9034 High Similarity NPC312942
0.9034 High Similarity NPC327095
0.899 High Similarity NPC40455
0.8744 High Similarity NPC470731
0.872 High Similarity NPC476817
0.8476 Intermediate Similarity NPC470732
0.8402 Intermediate Similarity NPC63279
0.8364 Intermediate Similarity NPC297642
0.8311 Intermediate Similarity NPC475969
0.8311 Intermediate Similarity NPC475859
0.8273 Intermediate Similarity NPC165743
0.8265 Intermediate Similarity NPC477175
0.8265 Intermediate Similarity NPC470730
0.8063 Intermediate Similarity NPC477177
0.8063 Intermediate Similarity NPC474877
0.8018 Intermediate Similarity NPC470729
0.8018 Intermediate Similarity NPC477176
0.774 Intermediate Similarity NPC294693
0.7593 Intermediate Similarity NPC54420
0.7523 Intermediate Similarity NPC162860
0.7364 Intermediate Similarity NPC478158
0.7348 Intermediate Similarity NPC56109
0.7348 Intermediate Similarity NPC191382
0.7346 Intermediate Similarity NPC473763
0.7346 Intermediate Similarity NPC117244
0.7342 Intermediate Similarity NPC31385
0.7342 Intermediate Similarity NPC75726
0.7342 Intermediate Similarity NPC110602
0.7319 Intermediate Similarity NPC478029
0.7302 Intermediate Similarity NPC171317
0.7285 Intermediate Similarity NPC107077
0.7285 Intermediate Similarity NPC223791
0.7281 Intermediate Similarity NPC155444
0.7281 Intermediate Similarity NPC31097
0.7277 Intermediate Similarity NPC478157
0.7257 Intermediate Similarity NPC281049
0.724 Intermediate Similarity NPC470491
0.7237 Intermediate Similarity NPC474896
0.7234 Intermediate Similarity NPC478028
0.723 Intermediate Similarity NPC471386
0.7228 Intermediate Similarity NPC56233
0.7222 Intermediate Similarity NPC220852
0.7222 Intermediate Similarity NPC473640
0.7217 Intermediate Similarity NPC128582
0.7203 Intermediate Similarity NPC285343
0.7202 Intermediate Similarity NPC475506
0.7188 Intermediate Similarity NPC75634
0.7181 Intermediate Similarity NPC477714
0.717 Intermediate Similarity NPC255909
0.7169 Intermediate Similarity NPC155143
0.716 Intermediate Similarity NPC14812
0.7156 Intermediate Similarity NPC94752
0.7156 Intermediate Similarity NPC54744
0.7137 Intermediate Similarity NPC477715
0.7136 Intermediate Similarity NPC469938
0.7123 Intermediate Similarity NPC17059
0.7118 Intermediate Similarity NPC272174
0.7115 Intermediate Similarity NPC11126
0.7104 Intermediate Similarity NPC214827
0.7104 Intermediate Similarity NPC473376
0.7104 Intermediate Similarity NPC314930
0.7091 Intermediate Similarity NPC182507
0.7087 Intermediate Similarity NPC161861
0.7081 Intermediate Similarity NPC24864
0.7073 Intermediate Similarity NPC91895
0.7062 Intermediate Similarity NPC228835
0.7032 Intermediate Similarity NPC313421
0.7032 Intermediate Similarity NPC100321
0.7028 Intermediate Similarity NPC99939
0.7028 Intermediate Similarity NPC308931
0.7026 Intermediate Similarity NPC64216
0.7021 Intermediate Similarity NPC69843
0.7009 Intermediate Similarity NPC475024
0.7009 Intermediate Similarity NPC213629
0.6995 Remote Similarity NPC194881
0.6995 Remote Similarity NPC17273
0.6995 Remote Similarity NPC135601
0.6995 Remote Similarity NPC141612
0.6991 Remote Similarity NPC320968
0.6986 Remote Similarity NPC64436
0.6965 Remote Similarity NPC314176
0.6962 Remote Similarity NPC89987
0.6952 Remote Similarity NPC248462
0.6934 Remote Similarity NPC143533
0.6926 Remote Similarity NPC478011
0.6926 Remote Similarity NPC478012
0.6919 Remote Similarity NPC15840
0.6917 Remote Similarity NPC28945
0.6917 Remote Similarity NPC125181
0.6917 Remote Similarity NPC242872
0.6917 Remote Similarity NPC263117
0.6917 Remote Similarity NPC314056
0.6916 Remote Similarity NPC478077
0.6878 Remote Similarity NPC293917
0.6864 Remote Similarity NPC475258
0.6864 Remote Similarity NPC476491
0.6858 Remote Similarity NPC475259
0.6858 Remote Similarity NPC471950
0.6858 Remote Similarity NPC471945
0.6852 Remote Similarity NPC103119
0.684 Remote Similarity NPC91179
0.684 Remote Similarity NPC16659
0.6836 Remote Similarity NPC478013
0.6833 Remote Similarity NPC149708
0.683 Remote Similarity NPC477179
0.683 Remote Similarity NPC317701
0.6828 Remote Similarity NPC471946
0.6828 Remote Similarity NPC471951
0.6825 Remote Similarity NPC157583
0.6822 Remote Similarity NPC472119
0.6806 Remote Similarity NPC472323
0.68 Remote Similarity NPC477181
0.68 Remote Similarity NPC254850
0.68 Remote Similarity NPC477178
0.68 Remote Similarity NPC477180
0.6796 Remote Similarity NPC478182
0.6792 Remote Similarity NPC265710
0.6792 Remote Similarity NPC12649
0.6791 Remote Similarity NPC79062
0.6791 Remote Similarity NPC472107
0.6787 Remote Similarity NPC153400
0.6786 Remote Similarity NPC476874
0.6773 Remote Similarity NPC57994
0.6773 Remote Similarity NPC289299
0.677 Remote Similarity NPC470490
0.677 Remote Similarity NPC477173
0.677 Remote Similarity NPC477174
0.6763 Remote Similarity NPC325976
0.676 Remote Similarity NPC314882
0.6751 Remote Similarity NPC909
0.6751 Remote Similarity NPC475338
0.6745 Remote Similarity NPC473380
0.6745 Remote Similarity NPC240088
0.6744 Remote Similarity NPC470003
0.674 Remote Similarity NPC323927
0.674 Remote Similarity NPC470488
0.6738 Remote Similarity NPC473310
0.6731 Remote Similarity NPC321939
0.6731 Remote Similarity NPC114637
0.6727 Remote Similarity NPC304203
0.6725 Remote Similarity NPC191817
0.6725 Remote Similarity NPC475359
0.6724 Remote Similarity NPC471192
0.6723 Remote Similarity NPC186351
0.6712 Remote Similarity NPC476460
0.6711 Remote Similarity NPC328596
0.6711 Remote Similarity NPC328318
0.671 Remote Similarity NPC317752
0.6709 Remote Similarity NPC474196
0.6698 Remote Similarity NPC163055
0.6697 Remote Similarity NPC175474
0.6697 Remote Similarity NPC321708
0.6696 Remote Similarity NPC317373
0.6695 Remote Similarity NPC238945
0.6695 Remote Similarity NPC79386
0.6693 Remote Similarity NPC315467
0.6683 Remote Similarity NPC40070
0.6682 Remote Similarity NPC474389
0.668 Remote Similarity NPC477516
0.6667 Remote Similarity NPC153980
0.6667 Remote Similarity NPC318299
0.6667 Remote Similarity NPC14325
0.6667 Remote Similarity NPC471194
0.6667 Remote Similarity NPC326363
0.6667 Remote Similarity NPC6865
0.6667 Remote Similarity NPC28848
0.6667 Remote Similarity NPC472116
0.6667 Remote Similarity NPC471193
0.6667 Remote Similarity NPC258480
0.6654 Remote Similarity NPC478006
0.6652 Remote Similarity NPC327592
0.665 Remote Similarity NPC293487
0.6638 Remote Similarity NPC313804
0.6638 Remote Similarity NPC315804
0.6637 Remote Similarity NPC193761
0.6636 Remote Similarity NPC129909
0.6636 Remote Similarity NPC133003
0.6635 Remote Similarity NPC478184
0.6629 Remote Similarity NPC477633
0.6625 Remote Similarity NPC33949
0.6623 Remote Similarity NPC238457
0.6623 Remote Similarity NPC72956
0.6622 Remote Similarity NPC106235
0.6622 Remote Similarity NPC239660
0.662 Remote Similarity NPC470205
0.6612 Remote Similarity NPC474183
0.6611 Remote Similarity NPC319232
0.6611 Remote Similarity NPC24370
0.661 Remote Similarity NPC474195
0.6607 Remote Similarity NPC212213
0.6607 Remote Similarity NPC52557
0.6606 Remote Similarity NPC66210
0.6604 Remote Similarity NPC477976
0.6604 Remote Similarity NPC242269
0.6602 Remote Similarity NPC478009
0.6602 Remote Similarity NPC478010
0.6596 Remote Similarity NPC475736
0.659 Remote Similarity NPC477003

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC253987 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7713 Intermediate Similarity NPD7661 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7195 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7594 Clinical (unspecified phase)
0.7488 Intermediate Similarity NPD7944 Discontinued
0.7444 Intermediate Similarity NPD8000 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7903 Clinical (unspecified phase)
0.7406 Intermediate Similarity NPD7619 Phase 3
0.7406 Intermediate Similarity NPD7618 Phase 3
0.7371 Intermediate Similarity NPD7789 Approved
0.7371 Intermediate Similarity NPD7791 Approved
0.7371 Intermediate Similarity NPD7952 Approved
0.7371 Intermediate Similarity NPD7790 Approved
0.7371 Intermediate Similarity NPD7953 Approved
0.7371 Intermediate Similarity NPD7951 Approved
0.7371 Intermediate Similarity NPD7950 Approved
0.7348 Intermediate Similarity NPD7781 Approved
0.7348 Intermediate Similarity NPD7780 Approved
0.7318 Intermediate Similarity NPD7666 Phase 3
0.7318 Intermediate Similarity NPD7665 Phase 2
0.7304 Intermediate Similarity NPD7731 Approved
0.7304 Intermediate Similarity NPD7730 Approved
0.7277 Intermediate Similarity NPD7970 Approved
0.7277 Intermediate Similarity NPD7971 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD8272 Phase 2
0.7241 Intermediate Similarity NPD7824 Approved
0.7217 Intermediate Similarity NPD7271 Approved
0.7175 Intermediate Similarity NPD7809 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6269 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6268 Phase 1
0.7149 Intermediate Similarity NPD7001 Phase 3
0.7143 Intermediate Similarity NPD7483 Phase 2
0.7143 Intermediate Similarity NPD7482 Phase 2
0.713 Intermediate Similarity NPD7023 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD7712 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6044 Discontinued
0.7032 Intermediate Similarity NPD7000 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6999 Discontinued
0.703 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD8114 Approved
0.7027 Intermediate Similarity NPD8169 Discontinued
0.7027 Intermediate Similarity NPD8115 Approved
0.6991 Remote Similarity NPD7470 Discontinued
0.6972 Remote Similarity NPD7818 Clinical (unspecified phase)
0.6966 Remote Similarity NPD7711 Discontinued
0.6966 Remote Similarity NPD8289 Discontinued
0.6964 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6955 Remote Similarity NPD6137 Clinical (unspecified phase)
0.692 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6916 Remote Similarity NPD8013 Clinical (unspecified phase)
0.6916 Remote Similarity NPD5820 Clinical (unspecified phase)
0.6892 Remote Similarity NPD5017 Discontinued
0.6892 Remote Similarity NPD7817 Phase 1
0.6884 Remote Similarity NPD7394 Phase 2
0.6878 Remote Similarity NPD7621 Clinical (unspecified phase)
0.6867 Remote Similarity NPD8246 Approved
0.6867 Remote Similarity NPD8247 Approved
0.6864 Remote Similarity NPD6664 Approved
0.6858 Remote Similarity NPD6520 Phase 3
0.6858 Remote Similarity NPD6521 Phase 3
0.6857 Remote Similarity NPD8375 Approved
0.6856 Remote Similarity NPD7557 Clinical (unspecified phase)
0.6844 Remote Similarity NPD2849 Clinical (unspecified phase)
0.684 Remote Similarity NPD8257 Approved
0.684 Remote Similarity NPD8258 Clinical (unspecified phase)
0.684 Remote Similarity NPD2787 Clinical (unspecified phase)
0.684 Remote Similarity NPD8256 Approved
0.6837 Remote Similarity NPD5809 Phase 3
0.6833 Remote Similarity NPD7204 Clinical (unspecified phase)
0.683 Remote Similarity NPD8072 Approved
0.6829 Remote Similarity NPD8250 Phase 2
0.6826 Remote Similarity NPD8242 Clinical (unspecified phase)
0.6822 Remote Similarity NPD7564 Discontinued
0.6814 Remote Similarity NPD8322 Phase 2
0.6814 Remote Similarity NPD5864 Phase 2
0.6806 Remote Similarity NPD3486 Clinical (unspecified phase)
0.6802 Remote Similarity NPD8371 Clinical (unspecified phase)
0.6787 Remote Similarity NPD2880 Discontinued
0.6784 Remote Similarity NPD2442 Approved
0.6784 Remote Similarity NPD2443 Approved
0.6781 Remote Similarity NPD5198 Approved
0.6781 Remote Similarity NPD5199 Approved
0.678 Remote Similarity NPD2511 Approved
0.6774 Remote Similarity NPD8110 Clinical (unspecified phase)
0.6773 Remote Similarity NPD4602 Approved
0.6773 Remote Similarity NPD8484 Phase 2
0.677 Remote Similarity NPD5489 Phase 1
0.677 Remote Similarity NPD5491 Phase 3
0.6766 Remote Similarity NPD8356 Approved
0.6763 Remote Similarity NPD2720 Phase 1
0.6763 Remote Similarity NPD2719 Clinical (unspecified phase)
0.6758 Remote Similarity NPD3430 Approved
0.6758 Remote Similarity NPD3431 Approved
0.6752 Remote Similarity NPD5884 Clinical (unspecified phase)
0.6748 Remote Similarity NPD6771 Discontinued
0.6741 Remote Similarity NPD7727 Phase 2
0.674 Remote Similarity NPD3905 Phase 3
0.6738 Remote Similarity NPD6470 Phase 3
0.6737 Remote Similarity NPD7717 Approved
0.6737 Remote Similarity NPD7716 Approved
0.6728 Remote Similarity NPD3961 Discontinued
0.6727 Remote Similarity NPD2717 Phase 2
0.6726 Remote Similarity NPD7049 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5426 Phase 3
0.6725 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6615 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6164 Phase 2
0.6723 Remote Similarity NPD6165 Phase 2
0.6723 Remote Similarity NPD8430 Approved
0.6713 Remote Similarity NPD5555 Phase 1
0.6712 Remote Similarity NPD7434 Approved
0.6712 Remote Similarity NPD6206 Phase 1
0.6711 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6711 Remote Similarity NPD8073 Approved
0.671 Remote Similarity NPD8094 Discontinued
0.6708 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6699 Remote Similarity NPD4639 Approved
0.6699 Remote Similarity NPD4638 Approved
0.6699 Remote Similarity NPD5862 Discovery
0.6699 Remote Similarity NPD4640 Approved
0.6698 Remote Similarity NPD5728 Clinical (unspecified phase)
0.6697 Remote Similarity NPD4334 Discontinued
0.6696 Remote Similarity NPD7568 Phase 1
0.6695 Remote Similarity NPD7823 Clinical (unspecified phase)
0.6695 Remote Similarity NPD8406 Clinical (unspecified phase)
0.6683 Remote Similarity NPD4326 Phase 2
0.6682 Remote Similarity NPD5508 Phase 1
0.6682 Remote Similarity NPD5505 Discontinued
0.6682 Remote Similarity NPD4615 Phase 2
0.6682 Remote Similarity NPD7026 Phase 2
0.6681 Remote Similarity NPD6888 Discontinued
0.6681 Remote Similarity NPD5887 Clinical (unspecified phase)
0.6681 Remote Similarity NPD5487 Phase 1
0.6667 Remote Similarity NPD6578 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7111 Discontinued
0.6667 Remote Similarity NPD8093 Discontinued
0.6667 Remote Similarity NPD7027 Phase 3
0.6667 Remote Similarity NPD4415 Approved
0.6667 Remote Similarity NPD6328 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5315 Discontinued
0.6653 Remote Similarity NPD8047 Clinical (unspecified phase)
0.6652 Remote Similarity NPD2405 Phase 3
0.6651 Remote Similarity NPD5636 Discontinued
0.6651 Remote Similarity NPD8408 Discontinued
0.6641 Remote Similarity NPD5461 Discontinued
0.6638 Remote Similarity NPD4959 Approved
0.6638 Remote Similarity NPD2357 Approved
0.6638 Remote Similarity NPD4960 Approved
0.6637 Remote Similarity NPD2881 Approved
0.6637 Remote Similarity NPD2879 Approved
0.6636 Remote Similarity NPD6180 Clinical (unspecified phase)
0.6636 Remote Similarity NPD6626 Approved
0.6636 Remote Similarity NPD3785 Clinical (unspecified phase)
0.6626 Remote Similarity NPD7807 Clinical (unspecified phase)
0.6625 Remote Similarity NPD7887 Approved
0.6625 Remote Similarity NPD7888 Approved
0.6622 Remote Similarity NPD8339 Clinical (unspecified phase)
0.6621 Remote Similarity NPD6965 Clinical (unspecified phase)
0.662 Remote Similarity NPD5104 Approved
0.6619 Remote Similarity NPD2390 Clinical (unspecified phase)
0.6617 Remote Similarity NPD7469 Discontinued
0.6611 Remote Similarity NPD7603 Discontinued
0.6609 Remote Similarity NPD7704 Clinical (unspecified phase)
0.6609 Remote Similarity NPD2408 Discontinued
0.6605 Remote Similarity NPD6595 Phase 3
0.6604 Remote Similarity NPD750 Phase 2
0.6603 Remote Similarity NPD4550 Clinical (unspecified phase)
0.6598 Remote Similarity NPD6986 Phase 1
0.6597 Remote Similarity NPD6173 Approved
0.6596 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6595 Remote Similarity NPD8458 Clinical (unspecified phase)
0.6595 Remote Similarity NPD4852 Phase 2
0.659 Remote Similarity NPD4957 Phase 2
0.6589 Remote Similarity NPD8122 Approved
0.6589 Remote Similarity NPD8123 Approved
0.6586 Remote Similarity NPD8291 Clinical (unspecified phase)
0.6584 Remote Similarity NPD4547 Phase 3
0.658 Remote Similarity NPD6204 Clinical (unspecified phase)
0.6578 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6575 Remote Similarity NPD8020 Approved
0.6575 Remote Similarity NPD5590 Clinical (unspecified phase)
0.6575 Remote Similarity NPD8021 Approved
0.6574 Remote Similarity NPD8101 Phase 3
0.657 Remote Similarity NPD8317 Phase 2
0.657 Remote Similarity NPD8316 Phase 2
0.6569 Remote Similarity NPD5986 Approved
0.6569 Remote Similarity NPD5987 Approved
0.6568 Remote Similarity NPD7203 Clinical (unspecified phase)
0.6567 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6567 Remote Similarity NPD5679 Clinical (unspecified phase)
0.6567 Remote Similarity NPD6787 Phase 2
0.6565 Remote Similarity NPD8260 Approved
0.6564 Remote Similarity NPD3015 Discontinued
0.6562 Remote Similarity NPD6224 Clinical (unspecified phase)
0.6561 Remote Similarity NPD1977 Clinical (unspecified phase)
0.6561 Remote Similarity NPD1658 Discontinued
0.6557 Remote Similarity NPD6970 Phase 2
0.6557 Remote Similarity NPD8159 Discontinued
0.6552 Remote Similarity NPD4614 Clinical (unspecified phase)
0.655 Remote Similarity NPD7289 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data